CoChat

Corticotropin-Releasing Hormone Stimulation Following Low-Dose Dexamethasone Administration: A New Test to Distinguish Cushing's Syndrome From Pseudo-Cushing's States

Yanovski, Jack A. · 1993 · JAMA

The DOI matches its Crossref record, with a small difference in title or year; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Objective. —The biochemical and phenotypic presentation of mild hypercortisolism in Cushing's syndrome is often indistinguishable from that seen in pseudo-Cushing's states such as depression. Both dexamethasone suppression and corticotropin-releasing hormone (CRH) stimulation tests have been used individually to distinguish these conditions, but neither approach has achieved a diagnostic accuracy greater than 85%. Therefore, we sought to develop a combined dexamethasone-CRH test that would take advantage of the altered sensitivity of patients with Cushing's syndrome to both dexamethasone and CRH and would achieve greater accuracy in the diagnosis of Cushing's syndrome. Design. —Prospective cohort study. Setting. —Tertiary care research hospital. Patients. —A total of 58 adults referred for evaluation of mild hypercortisolism (urine free cortisol level <1000 nmol/d). The diagnosis of Cushing's syndrome was confirmed at surgery in 39 patients. The diagnosis of a pseudo-Cushing's state was made in 19 patients on the basis of extended follow-up (mean, 28 months) without progression of cushingoid features. Intervention. —The low-dose dexamethasone suppression test, the CRH stimulation test, and the CRH stimulation test started 2 hours after completion of low-dose dexamethasone suppression (the dexamethasone-CRH test) were performed in all patients. Main Outcome Measures. —Sensitivity, specificity, and accuracy of the three procedures for diagnosis of Cushing's syndrome were calculated from plasma corticotropin, plasma cortisol, urine free cortisol, and urine 17-hydroxycorticosteroid values. Results. —The low-dose dexamethasone suppression test had 74% specificity, 69% sensitivity, and 71% diagnostic accuracy, using the standard criterion (17-hydroxycorticosteroid excretion level >11.0 μmol/d on the second day of dexamethasone administration). With a urine free cortisol criterion for Cushing's syndrome of greater than 100 nmol/d, the low-dose dexamethasone suppression test had 100% specificity, 56% sensitivity, and 71% diagnostic accuracy. The CRH stimulation test without dexamethasone pretreatment had 100% specificity, 64% sensitivity, and 76% diagnostic accuracy. The diagnostic accuracy of the dexamethasone-CRH test for Cushing's syndrome was significantly greater than the accuracy of either the low-dose dexamethasone test or the CRH test alone (P<.01). A plasma cortisol concentration greater than 38 nmol/L measured 15 minutes after the administration of CRH correctly identified all cases of Cushing's syndrome and all cases of pseudo-Cushing's states (100% specificity, sensitivity, and diagnostic accuracy). Conclusion. —The dexamethasone-CRH test is a more accurate test to distinguish Cushing's syndrome from pseudo-Cushing's states in patients with mild hypercortisolism. (JAMA. 1993;269:2232-2238)

Overview

Integrity signals

Registry

Crossref · 10.1001/jama.1993.03500170062035

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

The publisher hasn’t deposited this paper’s reference list.

Cited by

See all 313

Metadata

Authors
Yanovski, J. A.
Corresponding author
Yanovski, Jack A.
Venue
JAMA
Published
1993-05-05
Volume
269
Issue
17
Pages
2232
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4296465350
Cited by
205
References
0
Citations by year
2026: 7 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 9 · 2016: 5 · 2015: 10 · 2014: 5 · 2013: 3 · 2012: 5
FWCI
2.61
Type
journal article
Language
en
Open access
closed
Locations
JAMA (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Keywords
Cushing's syndrome, corticotropin-releasing hormone stimulation test, low-dose dexamethasone suppression test, depression, diagnostic accuracy, plasma ACTH, plasma cortisol, urinary free cortisol, 17-hydroxycorticosteroids, differential diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Corticotropin-Releasing Hormone Stimulation Following Low-Dose Dexamethasone Administration: A New Test to Distinguish Cushing's Syndrome From Pseudo-Cushing's States. https://app.cochat.ai/papers/10.1001/jama.1993.03500170062035
The paper
Yanovski, J. A. (1993). Corticotropin-Releasing Hormone Stimulation Following Low-Dose Dexamethasone Administration: A New Test to Distinguish Cushing's Syndrome From Pseudo-Cushing's States. JAMA. https://doi.org/10.1001/jama.1993.03500170062035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.